Atlas Trials

Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions

Clinical trial NCT06456086 · UNKNOWN

Trial details

NCT number
NCT06456086
Sponsor
First Affiliated Hospital of Kunming Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Adverse Drug Reactions
Start date
2020-12-01
Primary completion
2024-03-31
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.